COVID-19 Trials in Guadalajara, Mexico
Conditions / COVID-19 / Guadalajara, Mexico
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04352634 | The Covid-19 HEalth caRe wOrkErS (HEROES) Study | UNKNOWN | — |
| NCT04904549 | Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older | COMPLETED | PHASE3 |
| NCT04723394 | Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults | COMPLETED | PHASE3 |
| NCT05629962 | SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 | COMPLETED | PHASE3 |
| NCT04426695 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | COMPLETED | PHASE1/PHASE2 |
| NCT04350593 | Dapagliflozin in Respiratory Failure in Patients With COVID-19 | COMPLETED | PHASE3 |
| NCT04425629 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 | TERMINATED | PHASE3 |
| NCT04960202 | EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 | COMPLETED | PHASE2/PHASE3 |
| NCT05047601 | A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection | COMPLETED | PHASE2/PHASE3 |
| NCT05468736 | Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |